0001749423-18-000001.txt : 20180809 0001749423-18-000001.hdr.sgml : 20180809 20180809114054 ACCESSION NUMBER: 0001749423-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180809 DATE AS OF CHANGE: 20180809 EFFECTIVENESS DATE: 20180809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Symmune Therapeutics, LLC CENTRAL INDEX KEY: 0001749423 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-318830 FILM NUMBER: 181004077 BUSINESS ADDRESS: STREET 1: 212 WEST MAIN STREET STREET 2: SUITE 304 CITY: DURHAM STATE: NC ZIP: 27701 BUSINESS PHONE: 650-823-1706 MAIL ADDRESS: STREET 1: 212 WEST MAIN STREET STREET 2: SUITE 304 CITY: DURHAM STATE: NC ZIP: 27701 D 1 primary_doc.xml X0708 D LIVE 0001749423 Symmune Therapeutics, LLC 201 West Main Street B026 DURHAM NC NORTH CAROLINA 27701 650-823-1706 DELAWARE None None Limited Liability Company true 2015 Jesse Keicher 201 West Main Street B026 Durham NC NORTH CAROLINA 27701 Executive Officer Director Promoter Manager Biotechnology Decline to Disclose 06b false 2018-07-30 false true true true false 0 300000 125000 175000 false 5 0 0 0 Proceeds will be used for working capital which may include normal compensation to executive officers. false Symmune Therapeutics, LLC /s/ Jesse Keicher Jesse Keicher President 2018-08-08